Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Variability of Chemical Compositions and Antimicrobial and Antioxidant Activities of Ruta chalepensis Leaf Essential Oils from Three Palestinian Regions.

Jaradat N, Adwan L, K'aibni S, Zaid AN, Shtaya MJY, Shraim N, Assali M.

Biomed Res Int. 2017;2017:2672689. doi: 10.1155/2017/2672689. Epub 2017 Nov 5.

2.

Chemical composition, anthelmintic, antibacterial and antioxidant effects of Thymus bovei essential oil.

Jaradat N, Adwan L, K'aibni S, Shraim N, Zaid AN.

BMC Complement Altern Med. 2016 Oct 26;16(1):418.

3.

Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Adwan L, Subaiea GM, Basha R, Zawia NH.

J Neurochem. 2015 Apr;133(2):266-72. doi: 10.1111/jnc.12960. Epub 2014 Oct 18.

4.

Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid.

Subaiea GM, Ahmed AH, Adwan LI, Zawia NH.

J Alzheimers Dis. 2015;43(2):425-33. doi: 10.3233/JAD-132726.

PMID:
25096618
5.

Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Adwan L, Subaiea GM, Zawia NH.

Neuropharmacology. 2014 Apr;79:596-602. doi: 10.1016/j.neuropharm.2014.01.009. Epub 2014 Jan 21.

PMID:
24462621
6.

Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation.

Sankpal UT, Lee CM, Connelly SF, Kayaleh O, Eslin D, Sutphin R, Goodison S, Adwan L, Zawia NH, Lichtenberger LM, Basha R.

Cell Physiol Biochem. 2013;32(3):675-86. doi: 10.1159/000354471. Epub 2013 Sep 10.

7.

Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice.

Subaiea GM, Adwan LI, Ahmed AH, Stevens KE, Zawia NH.

Neurobiol Aging. 2013 Oct;34(10):2421-30. doi: 10.1016/j.neurobiolaging.2013.04.002. Epub 2013 Apr 30.

8.

Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.

Adwan L, Zawia NH.

Pharmacol Ther. 2013 Jul;139(1):41-50. doi: 10.1016/j.pharmthera.2013.03.010. Epub 2013 Apr 3. Review.

9.

Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway.

Adwan LI, Basha R, Abdelrahim M, Subaiea GM, Zawia NH.

Curr Alzheimer Res. 2011 Jun;8(4):385-92.

PMID:
21557719
10.

Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Dosunmu R, Wu J, Adwan L, Maloney B, Basha MR, McPherson CA, Harry GJ, Rice DC, Zawia NH, Lahiri DK.

J Alzheimers Dis. 2009;18(1):211-30. doi: 10.3233/JAD-2009-1138.

Supplemental Content

Support Center